3/25
04:10 pm
lfwd
Lifeward Successfully Closes on Strategic Partnership with Oramed
High
Report
Lifeward Successfully Closes on Strategic Partnership with Oramed
3/19
08:43 am
lfwd
Lifeward (LFWD) had its price target raised by HC Wainwright from $4.50 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Lifeward (LFWD) had its price target raised by HC Wainwright from $4.50 to $10.00. They now have a "buy" rating on the stock.
3/18
10:48 am
lfwd
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/18
08:00 am
lfwd
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
3/13
08:00 am
lfwd
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Low
Report
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
3/11
08:00 am
lfwd
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
3/10
04:15 pm
lfwd
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Medium
Report
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
3/2
08:00 am
lfwd
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
Medium
Report
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
2/25
08:00 am
lfwd
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
High
Report
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
2/20
08:00 am
lfwd
Lifeward Announces Reverse Share Split
Medium
Report
Lifeward Announces Reverse Share Split
2/17
08:00 am
lfwd
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
Medium
Report
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
1/13
08:00 am
lfwd
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Low
Report
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company